These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34172168)

  • 1. 50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction in Systemic Juvenile Idiopathic Arthritis with Alleviation of Arthritis: The First Description of Macrophage Activation Syndrome?
    Ashkenazi L; Hashkes PJ
    J Pediatr; 2021 Jul; 234():64. PubMed ID: 34172168
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset.
    Raghuram J; Gornale VK; Rao AP
    Indian Pediatr; 2021 Jan; 58(1):87. PubMed ID: 33452788
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease.
    Erkens R; Esteban Y; Towe C; Schulert G; Vastert S
    Rheum Dis Clin North Am; 2021 Nov; 47(4):585-606. PubMed ID: 34635293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.
    Kafle R; Bhatta A; Gami S; Sapkota A; Sharma D; Yadav A; Chikanbanjar VK
    JNMA J Nepal Med Assoc; 2021 Nov; 59(243):1166-1169. PubMed ID: 35199753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Activation Syndrome in a Child with Juvenile Idiopathic Arthritis Secondary to SARS-CoV-2.
    Akturk H; Tanyildiz M; Erbey F; Tasdemir M; Celikyurt A; Gonen E; Bilge I
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis.
    Takakura M; Shimizu M; Yakoyama T; Mizuta M; Yachie A
    Pediatr Int; 2018 Oct; 60(10):984-985. PubMed ID: 30345698
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.
    Kiuchi Z; Ogura M; Sato M; Kamei K; Ishikura K; Abe J; Ito S
    Scand J Rheumatol; 2019 May; 48(3):246-248. PubMed ID: 30406708
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage activation syndrome: Experience in the questioned role of etoposide.
    Conde LF; Aedo KP; Miraval-Niño de Guzmán T
    Reumatol Clin; 2017; 13(4):239-240. PubMed ID: 28041909
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin.
    Ozturk K; Ekinci Z
    Rheumatol Int; 2015 Oct; 35(10):1779-80. PubMed ID: 26210998
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
    Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
    World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia.
    Shi L; Hu F; Xu C; Zhu H; Qie D; Yuan C; Tao Y; Liu H
    Int J Rheum Dis; 2018 May; 21(5):1142-1145. PubMed ID: 28328098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Gorelik M; Fall N; Altaye M; Barnes MG; Thompson SD; Grom AA; Hirsch R
    J Rheumatol; 2013 Jul; 40(7):1191-9. PubMed ID: 23678162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Juvenile Idiopathic Arthritis.
    Lee JJY; Schneider R
    Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
    Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
    Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 17-year-old girl with severe respiratory failure and circulatory shock.
    Gutierrez D; Guy L; Katikireddi VS; Butler JP; Gowardman J
    Med J Aust; 2011 Oct; 195(7):414-5. PubMed ID: 21978351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.